Tag Archive: NCATS

NCATS “Rare Diseases Are Not Rare!” Challenge Now Open


        NCATS is seeking innovative ways to communicate with others to educate people about rare diseases through social media or art. The goals of this challenge, which is being led by NCATS’ Office of Rare Diseases Research, are to raise awareness for all rare diseases in a collective manner, to bring attention to the many people with rare diseases and to highlight the need for research and the development of new treatments. Use any communication you choose; be as creative and original as possible! Examples of entries include a music video, poem, painting, poster, animation, song, comic, … Continue reading

NCATS Funding Opportunity: Pfizer’s Center for Therapeutic Innovation Program


          Proposal Portal Now Open; Pre-Proposals Due November 2   NCATS announces an opportunity for NIH intramural researchers to submit proposals to collaborate with Pfizer’s Centers for Therapeutic Innovation (CTI). Pfizer’s CTI program, which is managed by NCATS, pairs NIH intramural researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. Goals include identifying biologic compounds with activity in a pathway or target of interest to both an NIH intramural researcher and Pfizer and moving the compounds into the clinic to test them. Areas of interest to Pfizer include cancer, autoimmunity/inflammation, metabolic … Continue reading

Register Now for NCATS Day 2018


        Participate in a robust dialogue about meaningful collaboration and help shape NCATS research priorities Don’t miss your opportunity to participate in NCATS Day 2018: Engaging Patients and Communities for Smarter Science on Sept. 28, 2018, from 8:30 a.m. to 5 p.m. on the NIH main campus in Bethesda, Maryland. This year’s event, which is focused on patient and community engagement, will provide a forum for participants to share and reflect upon patient and community needs as well as best practices for addressing those needs. Participants will learn strategies to broaden participation in research and to incorporate … Continue reading

NCATS Funding Opportunity: Repurpose Existing Drugs


        NCATS has released two funding opportunities aimed at identifying new treatments for a broad range of diseases using partially developed therapeutic candidates. NCATS has released two funding opportunities aimed at identifying new treatments for a broad range of diseases using partially developed therapeutic candidates. Through its Discovering New Therapeutic Uses for Existing Molecules program, NCATS helps academic researchers and pharmaceutical companies establish collaborations to test existing drugs and biologics for possible new uses. View the web announcement for funding details and application deadlines.

Apply for the NCAT/SBIR/STTR Funding by Sept 5


The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2018 Omnibus Grant Solicitations: SBIR: PA-18-574 STTR: PA-18-575 NCATS encourages applications that address a range of focus areas relevant to any stage of translation, from target validation through pre-clinical and clinical evaluation, to intervention implementation and dissemination, including: Drug Discovery and Development Biomedical, Clinical and Health Research Informatics Clinical, Dissemination and Implementation Research The deadline to apply is Sept. 5, 2018, 5:00 p.m. local time. Benefits of Applying: … Continue reading

Register Now for NCATS Day on Sept. 28, 2018


Registration is now open for NCATS Day 2018: Engaging Patients and Communities for Smarter Science on Sept. 28, 2018, from 8:30 a.m. to 5 p.m. on the NIH main campus in Bethesda, Maryland. The purpose of the event is to provide a forum to share and reflect upon patient and community needs — as well as best practices in addressing those needs — so that NCATS can best shape its research priorities, programs and initiatives. Patients and patient advocates, caregivers, community partners, community health engagement professionals, clinical and translational researchers, and others are urged to attend to share and discuss … Continue reading

Register Now for the NCATS and FDA Gene Therapy Approaches to Rare Diseases Workshop


Gene-based therapy is a promising and cutting-edge approach for the treatment of rare diseases. While these tailored therapies offer hope for patients, there are still many unanswered questions. To help facilitate discussion among academic, government and industry researchers, NCATS and the Food and Drug Administration’s Center for Biologics Evaluation and Research will co-host “The Growing Promise of Gene Therapy Approaches to Rare Diseases” workshop on Aug. 20-21, 2018. The event will take place at the National Institutes of Health main campus in Bethesda, Maryland. The goals of this two-day workshop include: Reviewing the state of current gene therapy approaches; Identifying … Continue reading

NCATS Stem Cell Translational Science Workshop Sept 26


Register Now for NCATS’ Stem Cell Translational Science Workshop On Sept. 26, 2017, NCATS will host the Workshop on Translational Challenges of Induced Pluripotent Stem Cells (iPSC) from 8:15 a.m. to 5 p.m. on the NIH campus in Bethesda, Maryland. The event will include discussions about iPSC collaborative opportunities and best practices in translational iPSC research. Workshop goals include: Highlighting the biological and technological challenges of advancing iPSCs into clinical applications and drug discovery; Evaluating the state-of-the field of iPSC translation and discussing critical steps for quality control, standardization and reproducibility; Discussing methods of protocol development/optimization and molecular and functional … Continue reading

Future Charges For Clinical Research Unit Services


Effective May 2018 The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), which supports the ICTR Clinical Research Units (CRUs) through its Clinical and Translational Science Award (CTSA) program, announced in 2014 that direct support of the CRUs will not be allowed for any new or re-competing CTSA awards.  Our CRUS have been a major source of support for investigators throughout Johns Hopkins and this change in policy will have a significant impact on our future ICTR operations.  This NCATS policy has already been implemented for the 18 CTSA “hubs” that received a new award … Continue reading